Tue, Mar 17, 2026 A practitioner has outlined the 'two problems' that may arise from taking proton pump inhibitors (PPI), ...

The use of potassium-competitive acid blockers or PPI with clopidogrel is associated with a higher risk for ischemic events ...

Since their development and widespread adoption in the late 1980s, proton pump inhibitors (PPI) have transformed the field of gastroenterology. Their high efficacy and favorable safety profiles have ...

A practitioner has explained the 'two problems' that may come with taking proton pump inhibitors (PPI), such as omeprazole, for a long time. Specialist, Simon Mills, shared the potential issues on an ...

Please provide your email address to receive an email when new articles are posted on . An intervention program was associated with an absolute reduction of 7.3% in patients who filled proton pump ...

The long term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric (stomach) cancer, finds ...

The potential link between use of proton pump inhibitors and gastric cancer has been an ongoing controversial subject since the drugs entered the market in the late 1980s. Long-term use of proton pump ...